KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Accured Expenses (2017 - 2026)

Twist Bioscience has reported Change in Accured Expenses over the past 10 years, most recently at $35.2 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 537.25% to $35.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $38.1 million through Mar 2026, up 15699.59% year-over-year, with the annual reading at $6.6 million for FY2025, 16.04% down from the prior year.
  • Change in Accured Expenses was $35.2 million for Q1 2026 at Twist Bioscience, up from -$12.4 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $35.2 million in Q1 2026 and troughed at -$12.4 million in Q4 2025.
  • The 5-year median for Change in Accured Expenses is -$456000.0 (2023), against an average of $2.7 million.
  • Year-over-year, Change in Accured Expenses soared 2232.46% in 2024 and then plummeted 1969.22% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$3.7 million in 2022, then crashed by 36.65% to -$5.1 million in 2023, then skyrocketed by 88.16% to -$601000.0 in 2024, then plummeted by 1969.22% to -$12.4 million in 2025, then soared by 383.28% to $35.2 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Change in Accured Expenses are $35.2 million (Q1 2026), -$12.4 million (Q4 2025), and $11.3 million (Q3 2025).